✦ LIBER ✦

PNL3 PREDICTORS FOR DIRECT AND INDIRECT COSTS IN PARKINSON'S DISEASE

✍ Scribed by U Siebert; B Bornschein; EA Spottke; K Berger; WH Oertel; R Dodel

Book ID: 119596966
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 66 KB
Volume: 7
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66108-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PNL3 THE COST-EFFECTIVENESS OF QUETIAPIN

PNL3 THE COST-EFFECTIVENESS OF QUETIAPINE FOR ALZHEIMER'S DISEASE IN COMMUNITY DWELLING PATIENTS

✍ D Getsios; I Proskorovsky; JJ Caro; J O'Brien; J Pesa; AJ Ward 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Direct and indirect costs of nephrolithi

Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management?

✍ SAIGAL, CHRISTOPHER S; JOYCE, GEOFFREY; TIMILSINA, ANGA R 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 77 KB

PNL4 NEW LEVODOPA/CARBIDOPA/ENTACAPONE (

PNL4 NEW LEVODOPA/CARBIDOPA/ENTACAPONE (STALEVO®) RESULTS IN BETTER QUALITY OF LIFE FOR PARKINSON'S DISEASE PATIENTS AND SAVES COSTS TO THE SOCIETY

✍ L Findley; H Turunen; M Apajasalo; A Lees 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PNL16 A COMPARATIVE STUDY ON RESOURCE US

PNL16 A COMPARATIVE STUDY ON RESOURCE USE, COSTS AND CAREGIVER BURDEN BETWEEN RASAGILINE AND ENTACAPONE IN FLUCTUATING PARKINSON'S DISEASE (PD) PATIENTS

✍ B Roch; N Despiegel; C François; T Goren 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

3.419 Predictors of functional ability a

3.419 Predictors of functional ability and quality of life in Parkinson's disease

✍ D. Muslimovic; B. Post; J.D. Speelman; R. de Haan; B. Schmand 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Direct costs of managing Parkinson's dis

Direct costs of managing Parkinson's disease in india: Concerns in a developing country

✍ Mona Ragothaman; Shyla T. Govindappa; Rohini Rattihalli; Dodaballapur K. Subbakr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

## Abstract Medicines and surgical interventions improve the quality of life of Parkinson's disease (PD) patients. These are still expensive options and are unaffordable to those living in developing countries. Managing PD in Indians who have a low annual gross national income (GNI; US$ 450–540) an